Matthew Weston
Stock Analyst at UBS
(1.54)
# 3,444
Out of 4,996 analysts
5
Total ratings
50%
Success rate
0.19%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Weston
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DBX Dropbox | Assumes: Sell | $29 → $27 | $31.43 | -14.08% | 1 | Sep 18, 2025 | |
| NVO Novo Nordisk | Downgrades: Neutral | n/a | $55.61 | - | 1 | Aug 5, 2025 | |
| NVS Novartis AG | Downgrades: Neutral | n/a | $123.65 | - | 1 | Feb 13, 2025 | |
| AZN AstraZeneca | Upgrades: Buy | n/a | $73.76 | - | 2 | Feb 13, 2025 |
Dropbox
Sep 18, 2025
Assumes: Sell
Price Target: $29 → $27
Current: $31.43
Upside: -14.08%
Novo Nordisk
Aug 5, 2025
Downgrades: Neutral
Price Target: n/a
Current: $55.61
Upside: -
Novartis AG
Feb 13, 2025
Downgrades: Neutral
Price Target: n/a
Current: $123.65
Upside: -
AstraZeneca
Feb 13, 2025
Upgrades: Buy
Price Target: n/a
Current: $73.76
Upside: -